These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1566488)

  • 1. Suramin as an anticomplementary agent in xenotransplantation.
    Carobbi A; Di Stefano R; Danesi R; Carmellini M; Ferrari M; Galatioto C; Ermini M; Mosca F
    Transplant Proc; 1992 Apr; 24(2):700. PubMed ID: 1566488
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation.
    Tanaka M; Murase N; Miyazawa H; Ye Q; Manez R; Todo S; Demetris AJ; Nomoto M; Miyazaki W; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):275-6. PubMed ID: 7533392
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary allogeneic challenge of xenotransplant recipients.
    Di Stefano R; Carobbi A; Frosini F; Ferrari M; Pelosi W; Rizzo G; Ermini M; Mosca F
    Transplant Proc; 1992 Apr; 24(2):694-5. PubMed ID: 1566485
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation.
    Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1284. PubMed ID: 7518126
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiments in cardiac xenotransplantation: fetal and neonatal exposure of graft recipients to xenogeneic cells.
    Mohiuddin M; Shen Z; Rostami S; DiSesa VJ
    Transplant Proc; 1994 Jun; 26(3):1306-7. PubMed ID: 8029916
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of graft survival in the concordant hamster-to-rat cardiac model.
    Brouard S; Blancho G; Moreau A; Heslan JM; Cuturi MC; Soulillou JP
    Transplant Proc; 1998 Aug; 30(5):2486-7. PubMed ID: 9723549
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of heart xenograft survival after liver hemoperfusion.
    Amorosa L; Gugenheim J; Saint-Paul MC; Benzaken S; Mouiel J
    Transplant Proc; 1990 Aug; 22(4):2002-3. PubMed ID: 2389509
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretransplant donor antigen and cyclophosphamide in the evaluation of the clonal deletion theory in the hamster to Lewis rat cardiac xenograft model.
    Boyle EM; Fischel RJ; Johnson EM; Leventhal J; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):698. PubMed ID: 1566486
    [No Abstract]   [Full Text] [Related]  

  • 10. Rejection and accommodation in the hamster-to-rat heart transplantation model.
    Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL
    Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac hyperacute rejection in concordant xenograft combinations induced by immunization.
    Wu GD; Cramer DV; Chapman FA; Wang HK; Hreha G; Ulker N; Makowka L
    Transplant Proc; 1992 Apr; 24(2):691-2. PubMed ID: 1566483
    [No Abstract]   [Full Text] [Related]  

  • 13. Extended and expanded studies of xenograft rejection in immunodeficient animals.
    Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
    Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic and xenogeneic cross-reactions in hyperimmune recipients.
    Di Stefano R; Carobbi A; Frosini F; Scavuzzo M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):446. PubMed ID: 8438372
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of xenograft rejection on future grafting.
    Gannedahl G; Tufveson G
    Transplant Proc; 1992 Feb; 24(1):276-8. PubMed ID: 1539281
    [No Abstract]   [Full Text] [Related]  

  • 16. Timing of splenectomy is critical in prolongation of cardiac xenografts.
    Araneda D; Carobbi A; Patselas T; Thomas F; Thomas J
    Transplant Proc; 1992 Apr; 24(2):523-4. PubMed ID: 1566415
    [No Abstract]   [Full Text] [Related]  

  • 17. Xenograft tolerance induced by intrathymic spleen cell injection.
    Sheffield CD; Hadley GH; Bartlett ST
    Transplant Proc; 1994 Jun; 26(3):1204. PubMed ID: 8029887
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of immunosuppressive drugs in xenografting.
    Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
    Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
    Johnson EM; Leventhal J; Dalmasso AP; Goswitz J; Simone P; Chen S; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):603. PubMed ID: 8623296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.